Prognostic value of cd200r1 mrna expression in head and neck squamous cell carcinoma

Hyun Chang, Yun Gyoo Lee, Yoon Ho Ko, Jang Ho Cho, Jong Kwon Choi, Keon Uk Park, Eun Joo Kang, Keun Wook Lee, Sun Min Lim, Jin Soo Kim, Hyun Woo Lee, Min Kyoung Kim, In Gyu Hwang, Sangwoo Kim, Byung Ho Nam, Hye Ryun Kim

    Research output: Contribution to journalArticlepeer-review

    8 Citations (Scopus)


    Immune system dysfunction is associated with head and neck squamous cell carcinoma (HNSCC) development and progression and immune checkpoint inhibitors have demonstrated substantial survival benefits in platinum-refractory HNSCC; therefore, we examined the prognostic value of immune-related gene (IRG) expression in HNSCC. We analyzed the expression of 82 IRGs in 71 patients with HNSCC enrolled in a feasibility study for a prospective HNSCC biomarker-driven umbrella trial (Korean Cancer Study Group TRIUMPH study, NCT03292250). CD200R1 was identified as an independent prognostic factor and validated in GEO and TCGA database. CD2000R1 mRNA expression was found to be an independent favorable prognostic factor in patients with HNSCC. Moreover, CD200R1 was found to affect genes and pathways associated with the immune response, while seven differentially expressed genes (CD8A, DOK2, CX3CR1, TYROBP, CXCL9, CD300LF, IFNG) were associated with CD200R1 expression. Samples with higher CD200R1 expression displayed higher tumor-infiltrating immune cell counts both in silico and in histological analysis. These findings will help in the development of more accurate prognostic tools and suggest CD200R1 modulation as a HNSCC immunotherapy.

    Original languageEnglish
    Article number1777
    Pages (from-to)1-14
    Number of pages14
    Issue number7
    Publication statusPublished - 2020 Jul

    Bibliographical note

    Funding Information:
    Funding: This research was funded by the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea, grant number HA16C0015.

    Publisher Copyright:
    © 2020 by the authors. Licensee MDPI, Basel, Switzerland.


    • CD2000R1
    • Head and neck cancer
    • Immune cell
    • MRNA expression
    • Prognosis

    ASJC Scopus subject areas

    • Oncology
    • Cancer Research


    Dive into the research topics of 'Prognostic value of cd200r1 mrna expression in head and neck squamous cell carcinoma'. Together they form a unique fingerprint.

    Cite this